Partner Headlines - ICPT

  1. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga
  2. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's ...

    Benzinga
  3. Benzinga's Top Initiations

    Benzinga
  4. Barclays Initiates Intercept Pharmaceuticals With Overweight

    Benzinga
  5. Intercept Pharmaceuticals Inc (ICPT) Moves Forward With OCA REGENERATE ...

    GuruFocus
  6. Intercept has a design for test

    IBD
  7. Intercept's NASH Trial Design Irks Investors

    IBD
  8. Will The Bulls In Options Continue To Be Disappointed This Week?

    Benzinga
  9. Analysts are Positive on Intercept Pharmaceuticals Inc Following ...

    GuruFocus
  10. Earnings Scheduled For March 2, 2015

    Benzinga
  11. Making Money With Charles Payne: 02/06/15

    FoxBusiness
  12. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals ...

    GuruFocus
  13. Cowen And Company Analyst Explains Why Intercept Pharmaceuticals ...

    Benzinga
  14. Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals ...

    Benzinga
  15. Mid-Afternoon Market Update: Crude Oil Jumps 7.5%; Visa Shares ...

    Benzinga
  16. Intercept Pharmaceuticals Soars 20%, Possible Short Squeeze

    Benzinga
  17. Mid-Day Market Update: Amazon Jumps On Upbeat Earnings; Hawaiian ...

    Benzinga
  18. Intercept Pharmaceuticals (ICPT) Obeticholic Acid Momentum, Gigamon ...

    GuruFocus
  19. Benzinga's Volume Movers

    Benzinga
  20. Mid-Morning Market Update: Markets Drop; Mastercard Profit Tops ...

    Benzinga
  21. Morning Market Gainers

    Benzinga
  22. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets ...

    Benzinga
  23. Stock Futures Sharpen Losses; Amazon, Visa, MasterCard Climb

    IBD
  24. Benzinga's Top #PreMarket Gainers

    Benzinga
  25. INTERCEPT PHARMACEUTICALS

    IBD
  26. Deutsche Bank: No Big Move In FY15 For Intercept Pharmaceuticals

    Benzinga
  27. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  28. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD
  29. IPO Stock Watch: FibroGen Up With Liver-Disease Field

    IBD
  30. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  31. Intercept Announces Publication Of Meta-Analysis From The Global ...

    Benzinga
  32. Here Are The Top 25 Analysts On Wall Street

    Benzinga
  33. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  34. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  35. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  36. Morning Market Losers

    Benzinga
  37. Benzinga's Top #PreMarket Losers

    Benzinga
  38. Meet The 5 Companies Loving Obamacare

    Benzinga
  39. Morning Market Losers

    Benzinga
  40. Benzinga's Top #PreMarket Losers

    Benzinga
  41. Benzinga's Top Initiations

    Benzinga
  42. Cowen Initiates Intercept At Outperform

    Benzinga
  43. Four biotech takeover targets?

    IBD
  44. 4 Biotechs That Might Be Bought Soon

    IBD
  45. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  46. Morning Market Losers

    Benzinga
  47. Benzinga's Top #PreMarket Losers

    Benzinga
  48. CNBC's Stock Pops & Drops From August 12

    Benzinga
  49. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  50. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  51. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  52. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  53. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  54. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  55. Benzinga's Volume Movers

    Benzinga
  56. Morning Market Movers

    Benzinga
  57. Conatus Shares Move Higher On Industry Data

    Benzinga
  58. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  59. Benzinga's Top #PreMarket Gainers

    Benzinga
  60. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  61. INTERCEPT PHARMACEUTICALS

    IBD
  62. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  63. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  64. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  65. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  66. Benzinga's Top Initiations

    Benzinga
  67. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  68. Top Healthcare Movers For June 9, 2014

    Benzinga
  69. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  70. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  71. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  72. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  73. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  74. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  75. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  76. Top Trending Tickers On StockTwits For March 17

    Benzinga
  77. Benzinga's Top #PreMarket Losers

    Benzinga
  78. Morning Gainers for Friday, March 14, 2014

    Benzinga
  79. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  80. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators ...

    Benzinga
  81. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  82. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
  83. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2 ...

    Benzinga
  84. Mid-Morning Market Update: Markets Rise; Bank of America Profit ...

    Benzinga
  85. Benzinga's Top #PreMarket Gainers

    Benzinga
  86. Market Wrap For January 14: Markets Rebound On Earnings Season ...

    Benzinga
  87. Mid-Afternoon Market Update: Markets Continue Rally as Tesla ...

    Benzinga
  88. Stocks Up In Afternoon; Tesla Soars On Strong Sales

    IBD
  89. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  90. Morning Market Losers

    Benzinga
  91. Benzinga's Top #PreMarket Losers

    Benzinga
  92. Intercept Reports Additional Details About FLINT Clinical Trial ...

    Benzinga
  93. Intercept to Present at the JP Morgan Healthcare Conference on ...

    Benzinga
  94. Market Wrap For January 10: Job Growth Weak, But Unemployment ...

    Benzinga
  95. Mid-Afternoon Market Update: Plug Rises on Secondary Pricing ...

    Benzinga
  96. Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; ...

    Benzinga
  97. Intercept Shares Skyrocket 500% This Week

    FoxBusiness
  98. Mid-Morning Market Update: Markets Drop; Alcoa Q4 Earnings Miss ...

    Benzinga
  99. Bank of America Reiterates on Intercept Pharmaceuticals

    Benzinga
  100. Benzinga's Volume Movers

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!